LNTHLantheus Holdings, Inc.
101.10USD-1.85%Mkt Cap: 6.65B USDP/E: 24.42Last update: 2026-05-26

Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in diagnosis and treatment of heart, cancer, and other diseases worldwide. The company offers …

Indicators:|

Key Statistics

Company
Market Cap6.65B USD
Enterprise Value6.28B USD
Revenue (TTM)1.55B USD
Gross Profit941.95M USD
Net Income (TTM)233.56M USD
Revenue/Share23.25 USD
Last Price101.10 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees1.2K
CountryUS
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISINUS5165441032
Valuation
P/E (Trailing)24.42
P/E (Forward)14.82
PEG
EV/EBITDA17.14
EV/Revenue4.06
P/S3.98
P/B5.07
EPS (TTM)4.19
EPS (Forward)6.37
52W Range
47.2595% of range103.89
52W High103.89 USD
52W Low47.25 USD
Profitability
Gross Margin61.10%
Oper. Margin21.65%
EBITDA Margin23.69%
Profit Margin15.15%
ROE21.43%
ROA10.49%
Growth
Revenue Growth1.20%
Earnings Growth76.50%
Cash Flow & Leverage
Operating CF390.14M USD
CapEx (TTM)41.50M USD
FCF Margin27.27%
FCF Yield6.35%
Net Debt127.17M USD
Net Debt/EBITDA0.35
Balance Sheet
Debt/Equity0.57
Current Ratio2.83
Quick Ratio2.57
Book Value/Sh18.63 USD
Cash/Share7.658 USD
Dividends
Fwd Div Rate
Trail. Div Rate0.0000 USD
Div. Yield
5Y Avg Yield
Payout Ratio0.00%
Ex-Div Date
Pay Date
Analyst Consensus
Rating1.5 (Strong Buy)
Target (Mean)104.08 USD
Target Range76.00 USD117.00 USD
# Analysts13
Ownership
Shares Out.65.11M
Float58.38M
Insiders2.09%
Institutions115.70%
Short Interest
Short Ratio8.2d
Short % Float11.60%
Short % Out.8.72%
Shares Short5.67M
Short (prev mo.)5.36M
Technical
SMA 5083.50 (+21.1%)
SMA 20066.52 (+52.0%)
Beta-0.08
S&P 52W Chg28.31%
Avg Vol (30d)936.80K
Avg Vol (10d)1.08M
Technical Indicators
RSI (14)
MACD
MACD Signal
MACD Hist.
BB Upper
BB Middle
BB Lower
BB Width
ATR (14)
Vol Ratio (20d)